In this issue:
Clinical outcomes of sacubitril/valsartan in acute HF
Sacubitril/valsartan vs. standard therapy: NT-proBNP and exercise capacity in HFPEF
Simple risk score for predicting frailty in hospitalised HF patients
30-day all-cause rehospitalisation/mortality in hospitalised HF
HF, acute MI and stroke hospitalisation trends in the US
HF incidence trends in New Zealand
Metformin and sulfonylureas in comorbid HF and diabetes
Please login below to download this issue (PDF)